Ocular Therapeutix, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SUMMER ROAD LLC | 02/11/2025 | 13.87 M | $118.45 M | -3.67% | 8.31% |
| DEEP TRACK CAPITAL, LP | 02/14/2025 | 12.84 M | $109.62 M | 0.90% | 7.69% |
| VR ADVISER, LLC | 02/14/2025 | 12.76 M | $108.99 M | 0.00% | 7.64% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 11.85 M | $101.17 M | 4.34% | 7.09% |
| VANGUARD GROUP INC | 02/11/2025 | 8.48 M | $72.45 M | 1.19% | 5.08% |
| AVORO CAPITAL ADVISORS LLC | 02/14/2025 | 8.06 M | $68.83 M | 0.00% | 4.83% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/14/2025 | 5.32 M | $45.43 M | 0.00% | 3.19% |
| OPALEYE MANAGEMENT INC. | 02/14/2025 | 4.34 M | $37.08 M | -13.58% | 2.60% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 3.60 M | $30.74 M | -4.00% | 2.16% |
| LOGOS GLOBAL MANAGEMENT LP | 02/14/2025 | 3.50 M | $29.89 M | 0.00% | 2.10% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 3.24 M | $27.64 M | -1.07% | 1.94% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 2.94 M | $25.07 M | 43.87% | 1.76% |
| DELTEC ASSET MANAGEMENT LLC | 01/27/2025 | 2.62 M | $22.34 M | 0.63% | 1.57% |
| OCTAGON CAPITAL ADVISORS LP | 02/14/2025 | 2.43 M | $20.71 M | 0.00% | 1.45% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 02/12/2025 | 1.33 M | $11.40 M | 26.38% | 0.80% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 1.17 M | $9.99 M | 0.00% | 0.70% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 1.13 M | $9.66 M | 1.89% | 0.68% |
| ROSALIND ADVISORS, INC. | 02/14/2025 | 1.13 M | $9.64 M | 27.54% | 0.68% |
| ACUTA CAPITAL PARTNERS, LLC | 02/14/2025 | 1.11 M | $9.49 M | -6.64% | 0.67% |
| PERCEPTIVE ADVISORS LLC | 02/14/2025 | 1.08 M | $9.21 M | -67.56% | 0.65% |
| WOODLINE PARTNERS LP | 02/14/2025 | 1.00 M | $8.56 M | 0.24% | 0.60% |
| INVESCO LTD. | 02/13/2025 | 890,046 | $7.60 M | 17.81% | 0.53% |
| UBS GROUP AG | 02/14/2025 | 876,546 | $7.49 M | 28.00% | 0.52% |
| CETERA INVESTMENT ADVISERS | 02/14/2025 | 723,840 | $6.18 M | 0.60% | 0.43% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 672,622 | $5.74 M | 16.73% | 0.40% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 638,964 | $5.46 M | -34.63% | 0.38% |
| AXA S.A. | 02/14/2025 | 637,832 | $5.45 M | -0.16% | 0.38% |
| KNOLL CAPITAL MANAGEMENT, LLC | 02/18/2025 | 600,400 | $5.13 M | 0.00% | 0.36% |
| PATIENT SQUARE CAPITAL LP | 02/14/2025 | 470,919 | $4.02 M | 99.97% | 0.28% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 467,352 | $3.99 M | 0.97% | 0.28% |
| FMR LLC | 02/13/2025 | 460,447 | $3.93 M | 6.00% | 0.28% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 456,120 | $3.90 M | -45.28% | 0.27% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 447,237 | $3.82 M | 100.00% | 0.27% |
| PALE FIRE CAPITAL SE | 02/13/2025 | 444,813 | $3.80 M | 1.51% | 0.27% |
| PANAGORA ASSET MANAGEMENT INC | 02/13/2025 | 437,737 | $3.74 M | 65.59% | 0.26% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 437,728 | $3.74 M | -37.47% | 0.26% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 420,231 | $3.59 M | -0.99% | 0.25% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 414,104 | $3.54 M | -17.60% | 0.25% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 02/18/2025 | 400,000 | $3.42 M | 0.00% | 0.24% |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 02/25/2025 | 394,400 | $3.37 M | -19.98% | 0.24% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 02/07/2025 | 387,248 | $3.31 M | -12.72% | 0.23% |
| VOYA INVESTMENT MANAGEMENT LLC | 02/14/2025 | 371,235 | $3.17 M | 35.67% | 0.22% |
| SECOND LINE CAPITAL, LLC | 02/14/2025 | 340,098 | $2.90 M | 29.41% | 0.20% |
| APTUS CAPITAL ADVISORS, LLC | 02/14/2025 | 339,750 | $2.90 M | 29.28% | 0.20% |
| BARCLAYS PLC | 02/13/2025 | 331,242 | $2.83 M | -35.24% | 0.20% |
| UBS OCONNOR LLC | 02/14/2025 | 270,422 | $2.31 M | 22.00% | 0.16% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 252,939 | $2.16 M | 21.94% | 0.15% |
| 02/10/2025 | 235,800 | $1.99 M | 0.00% | 0.14% | |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 218,588 | $1.87 M | 48.01% | 0.13% |
| RHUMBLINE ADVISERS | 01/30/2025 | 213,601 | $1.82 M | 2.73% | 0.13% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ocular Therapeutix, Inc. institutional Ownership - FAQ's
During the previous two years, 213 institutional investors and hedge funds held shares of Ocular Therapeutix, Inc.. The most heavily invested institutionals were:
SUMMER ROAD LLC: 13.87 M
Deep Track Capital, LP: 12.84 M
VR Adviser, LLC: 12.76 M
BlackRock Funding, Inc. /DE: 11.85 M
VANGUARD GROUP INC: 8.48 M
Avoro Capital Advisors LLC: 8.06 M
80.15% of Ocular Therapeutix, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 143.67 M shares in the last 24 months. This purchase volume represents approximately $1.28 B in transactions.